Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES)

被引:56
|
作者
Titus-Ernstoff, Linda
Troisi, Rebecca
Hatch, Elizabeth E.
Wisei, Lauren A.
Palmer, Julie
Hyer, Marianne
Kaufman, Raymond
Adam, Ervin
Strohsnitter, William
Noller, Kenneth
Herbst, Arthur L.
Gibson-Chambers, Jennifer
Hartge, Patricia
Hoover, Robert N.
机构
[1] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH 03756 USA
[2] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA
[3] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[4] Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02118 USA
[5] Boston Univ, Sch Publ Hlth, Slone Epidemiol Ctr, Boston, MA 02215 USA
[6] Informat Management Serv Inc, Rockville, MD 20852 USA
[7] Methodist Hosp, Dept Obstet & Gynecol, Houston, TX 77030 USA
[8] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA
[9] Tufts Univ New England Med Ctr, Dept Obstet & Gynecol, Boston, MA 02111 USA
[10] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA
关键词
diethylstilbestrol; prenatal exposure; maternal exposure; menstruation; reproductive histories; infertility; epigenetic alternations;
D O I
10.1093/ije/dyl106
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background In women, prenatal exposure to diethylstilbestrol (DES) is associated with adult reproductive dysfunction. The mouse model, which replicates many DES outcomes, suggests DES causes epigenetic alterations, which are transmissable to daughters of prenatally exposed animals. We report menstrual and reproductive characteristics in a unique cohort comprising daughters of women exposed prenatally to DES. Methods Menstrual and reproductive outcomes and baseline characteristics were assessed by mailed questionnaire in 793 women whose mothers had documented information regarding in utero DES exposure. Results Mean age at menarche was 12.6 years in both groups, but daughters of the exposed women attained menstrual regularization later (mean age of 16.2 years vs. 15.8 years; P = 0.05), and were more likely to report irregular menstrual periods, odds ratio (OR) = 1.54 [95% confidence interval (95% CI 1.02-2.32)]. A possible association between mothers' DES exposure and daughters' infertility was compatible with chance, age, and cohort adjusted OR = 2.19 (95% CI 0.95-5.07). We found limited evidence that daughters of the exposed had more adverse reproductive outcomes, but daughters of exposed women had fewer live births (1.6) than the unexposed (1.9) (P = 0.005). Conclusions The high risk of reproductive dysfunction seen in women exposed to DES in utero was not observed in their daughters, but most women in our cohort have not yet attempted to start their families, and further follow-up is needed to assess their reproductive health. Our findings of menstrual irregularity and possible infertility in third-generation women are preliminary but compatible with speculation regarding transgenerational transmission of DES-related epigenetic alterations in humans.
引用
收藏
页码:862 / 868
页数:7
相关论文
共 50 条
  • [21] ONSET OF MENOPAUSE IN WOMEN EXPOSED TO DIETHYLSTILBESTROL IN-UTERO
    HORNSBY, PP
    WILCOX, AJ
    HERBST, AL
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (01) : 92 - 95
  • [22] Age at natural menopause in women exposed to diethylstilbestrol in utero
    Hatch, Elizabeth E.
    Troisi, Rebecca
    Wise, Lauren A.
    Hyer, Marianne
    Palmer, Julie R.
    Titus-Ernstoff, Linda
    Strohsnitter, William
    Kaufman, Raymond
    Adam, Ervin
    Noller, Kenneth L.
    Herbst, Arthur L.
    Robboy, Stanley
    Hartge, Patricia
    Hoover, Robert N.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 164 (07) : 682 - 688
  • [23] Age at natural menopause in women exposed to diethylstilbestrol in utero
    Hatch, E.
    Troisi, R.
    Wise, L.
    Hyer, M.
    Palmer, J.
    Titus-Ernstoff, L.
    Strohsnitter, W.
    Kaufmann, R.
    Adam, E.
    Noller, K.
    Herbst, A.
    Robboy, S.
    Hartge, P.
    Hoover, R.
    EPIDEMIOLOGY, 2006, 17 (06) : S192 - S193
  • [24] SEMEN ANALYSIS IN MALES EXPOSED IN UTERO TO DIETHYLSTILBESTROL (DES) OR PLACEBO
    SCHUMACHER, GFB
    GILL, WB
    HUBBY, MM
    BLOUGH, RR
    IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 1981, 9 (02): : 100 - 101
  • [25] Birth defects in children of men exposed in utero to diethylstilbestrol (DES)
    Tournaire, Michel
    Devouche, Emmanuel
    Epelboin, Sylvie
    Cabau, Anne
    Dunbavand, Annabel
    Levadou, Anne
    THERAPIE, 2018, 73 (05): : 399 - 407
  • [26] HIRSUTISM AND MENSTRUAL PATTERNS IN WOMEN EXPOSED TO DIETHYLSTILBESTROL INUTERO
    PERESS, MR
    TSAI, CC
    MATHUR, RS
    WILLIAMSON, HO
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 144 (02) : 135 - 140
  • [27] Breast cancers in women with in utero exposure to diethylstilbestrol (DES)
    Schwartz, Arnold A.
    Rezaei, M. Katayoon
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (04) : 653 - 653
  • [28] REPRODUCTIVE HISTORY OF WOMEN EXPOSED TO DIETHYLSTILBESTROL INUTERO
    SCHMIDT, G
    FOWLER, WC
    TALBERT, LM
    EDELMAN, DA
    FERTILITY AND STERILITY, 1980, 33 (01) : 21 - 24
  • [29] REPRODUCTIVE OUTCOME OF WOMEN EXPOSED TO DIETHYLSTILBESTROL INUTERO
    COUSINS, L
    KARP, W
    LACEY, C
    LUCAS, WE
    OBSTETRICS AND GYNECOLOGY, 1980, 56 (01): : 70 - 76
  • [30] Reproductive outcome and infertility in women exposed to diethylstilbestrol in utero. A retrospective study by questionnaire of 258 women exposed and 50 unexposed siblings
    Cabau, A
    Lion, O
    CONTRACEPTION FERTILITE SEXUALITE, 1996, 24 (04): : 253 - 258